Description
Avantor Raises 2026 Guidance: Can Its Growth Recovery Gain Momentum?
Avantor, Inc. reported third-quarter 2026 results reflecting a return to year-over-year growth with net sales of $1,698.3 million, marking a 4.6% increase from the prior year. On an organic basis, net sales grew 5.2%, driven primarily by the VWR Distribution & Services segment which saw organic growth of 5.8%. The Bioscience & Medtech Products segment returned to organic growth at 3.6%, after a period of decline. These top-line improvements contributed to adjusted net income of $146.4 million, slightly lower than the prior year’s $151.1 million, alongside adjusted EBITDA of $256.9 million, representing a margin of 15.1%. GAAP net income improved significantly to $203.4 million from a net loss of $711.8 million in the same quarter in 2025, aided by the absence of the previous year’s $785 million goodwill impairment charge related to the Distribution reporting unit. Diluted GAAP earnings per share was reported at $0.



